Family · New Orleans, LA Metro · September 9, 2026
5th Circuit to Hear Case on Abortion Pill Mail Rules, Louisiana Ban at Stake
What Alinsky tactic is being used
3 of the thirteen rules are in play here — campaigns rarely run just one.
Rule 7
“A tactic that drags on too long becomes a drag.”
The clock, not the merits, is doing most of the work here: the district court paused the case in April 2026 to await an FDA safety review with only a status report due by October 7, 2026, and the administration has asked courts to hold off ruling until that review is done — a request the alert notes would push the issue past the midterms. The May 1 Fifth Circuit stay was itself undone by the Supreme Court on May 14, so the visible outcome has already flipped twice in two weeks. Attention burns out long before dockets do.
Counter-Rule 7 · Strategic Steadfastness
Outlast it. Novelty is the attacker's fuel and it runs out faster than patience does.
Put the dates in a calendar rather than in your memory: September 9, 2026 (oral argument), October 7, 2026 (FDA status report), and set a reminder to check the Fifth Circuit docket in No. 26-30203 each month. Sign up for the court's electronic notices or one law-firm alert list so you are reading orders rather than reactions. Plan on following this into 2027 and tell your group that up front, so nobody treats one hearing as the end.
Rule 3
“Whenever possible, go outside the expertise of the enemy.”
The dispute has been moved onto ground almost no lay advocate on either side is fluent in: it turns on Administrative Procedure Act review of the FDA's 2023 REMS, whether Louisiana has standing to sue over another state's mailings, and what an adequate safety analysis looks like. The alert itself frames the criticism as "inadequate safety analysis" — a regulatory-process claim, not a moral one. Whoever cannot speak that language is a spectator in their own cause.
Counter-Rule 3 · Preparation and Width
Prepare the unfamiliar ground before you are dragged onto it. "I don't know, I'll find out and come back" beats an improvised answer.
Read the Fifth Circuit's May 1 stay order itself (it is posted publicly as a PDF) and learn three terms cold: REMS, in-person dispensing requirement, and stay pending appeal. When someone at church asks whether the ruling banned the pill, answer only what the order says — it addressed federal dispensing rules, not Louisiana's criminal statute. If asked something you have not read, say "I don't know, I'll find out," and then do.
Rule 11
“If you push a negative hard and deep enough, it will break through into its counterside.”
Both sides are pushing the claim to its maximum: the headline says Louisiana's ban is "at stake," while opponents described the May 1 order as blocking the drug nationwide. Neither is quite what happened — the Fifth Circuit stay reinstated an in-person dispensing rule, the Supreme Court paused it on May 14, and Louisiana's own ban was never the thing the court was ruling on. Repeat the overclaim in public and you lose the argument on a detail.
Counter-Rule 11 · Proportional Truth
Refuse to overclaim, even where it would help. One exaggeration hands the other side the only weapon that works permanently.
Write down the narrow, true sentence before you speak: a federal appeals court is deciding whether the FDA followed proper procedure in allowing mail and pharmacy dispensing, and mail access remains in place for now. Refuse to say the ban is being struck down or that the pill has been banned, even when it would land better. Correct it, gently, when someone in your own circle says it.
Chapter 3 sets out the rules; Chapter 15 answers each of them in turn. This is that pairing applied to this story.
Know where you stand
The free 4-minute assessment identifies your mountain and your institution’s capture phase — so alerts like this one arrive matched to where you actually stand.
Facing this yourself? Ask. Describe what is happening and get what the book, Scripture, and the law of your state say, with the exact words to use. Your first one is free.